Nasdaq · CIK 0001755237
KRSA Cyclerion Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 32 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at Cyclerion Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Slate Path Capital LP owner sell | $555k 357,880 shares | -100% | - |
Transactions
The last 8 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Fairmount Funds Management LLC director, owner | AGrant or award Stock Option (Right to Buy)derivativeindirect: By: Tomas Kiselak | +48,445 | $0.00 | $0 | 48,445 | 32 d ago |
| Sep 9, 2026 | Andrew Gottesdiener director | AGrant or award Stock Option (Right to Buy)derivative | +48,445 | $0.00 | $0 | 48,445 | 32 d ago |
| Sep 9, 2026 | Nimish P Shah director | AGrant or award Stock Option (Right to Buy)derivative | +48,445 | $0.00 | $0 | 48,445 | 32 d ago |
| Sep 9, 2026 | Michelle Patricia Pernice director | AGrant or award Stock Option (Right to Buy)derivative | +48,445 | $0.00 | $0 | 48,445 | 32 d ago |
| Aug 7, 2025 | Rhonda M. Chicko Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Aug 11, 2025 |
| Mar 25, 2025 | Michael J Higgins director | AGrant or award Common Stock | +9,090 | $2.75 | $25k | 30,740 | Mar 27, 2025 |
| Mar 25, 2025 | Peter M Hecht director, owner | AGrant or award Common Stock | +181,818 | $2.75 | $500k | 559,203 | Mar 27, 2025 |
| Nov 21, 2024 | Slate Path Capital LP owner | SOpen-market sale Common Stock, no par valueindirect: See footnote | -357,880 | $1.55 | $555k | 0 | Nov 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Rhonda M. ChickoChief Financial Officer
- Fairmount Funds Management LLCdirector, owner
- Andrew Gottesdienerdirector
- Peter M Hechtdirector, owner
- Michael J Higginsdirector
- Michelle Patricia Pernicedirector
- Nimish P Shahowner, director
- Slate Path Capital LPowner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.